System solutions from seca define new measuring standards and optimize workflows in hospitals around the world
Within the scope of Medicine 4.0, seca has long since moved beyond its strong portfolio of medical scales and height-measuring devices. For many years the company has made substantial investments in EMR-ready measuring solutions which optimize the ad hoc assessment of the patient's state of health. At this year's Arab Health seca will be presenting integrated system solutions that increase efficiency and patient safety in hospitals worldwide. At Hall 2 Stand H2.C19 visitors will see how seca optimizes workflows and taps diagnostic potential.
Validated BIA from seca conforms to consensus on diagnostic methods
The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.
German medical technology company to build on successful projects in viable Benelux markets
Right on the heels of the November opening of the seca | lietuva site, the market leader in medical measuring systems and scales has opened its 16th international subsidiary seca | benelux. The company sees great potential in the progressive healthcare sector in Benelux countries and opportunities for sales, particularly of its EMR-ready and digital measuring solutions.
seca, the global market leader in medical measuring systems and scales, is opening its 15th branch in the Lithuanian capital of Vilnius. With the establishment of the first site dedicated to development only, seca is driving forward its digital transformation from a scale manufacturer to a software and system provider. seca will first hire 10 IT specialists to develop a new software solution that will take seca into new medical business fields. The team is expected to grow to 25 employees by 2021.
"The improvement in body composition is more important than weight loss alone."
On the occasion of World Obesity Day (11 October), a current representative survey contracted by seca, the leading manufacturer of medical measuring systems and scales, shows that nearly three-quarters (74%) of respondents (with BMI 30 and higher) have attempted to lose weight, but only 15% have been able to reach their goal and maintain their weight. Reasons for failure included lack of persistence (44%), frustration when success does not come as quickly as desired (42%) and not believing in one's ability to succeed (28%).
Talking about being overweight with the doctor is taboo.
In many countries patients often do not see the doctor until after they've been weighed, but in the United Kingdom, a regular, standardised weighing rarely takes place in medical practices – although there is a protocol in the UK to weigh a patient at least once a year should they visit the practice. It's time for action. A representative survey contracted by seca, the leading manufacturer of medical measuring systems and scales, has shown that 42 percent of Britons are overweight and the average Body Mass Index (BMI) is 27.5. Weights are rising too. Within the past five years, 44 percent have gained weight, with 11 percent reporting gains of 15 kilograms or even more. Nevertheless, the...
Quality management satisfies global requirements and secures seca competitive advantages
The German and French quality management systems of seca, the leading manufacturer of medical measuring systems and scales, have been certified according to the revised standards ISO 9001 and ISO 13485 in an audit conducted by TÜV-Süd. In addition, the quality management system at seca headquarters in Hamburg received the Medical Device Single Audit Program (MDSAP) certificate. It shows that seca officially satisfies not only the legal requirements in Europe, but also in the USA, Canada, Australia, Japan and Brazil.